Family Medicine Doctors in Augusta, ME Accepting Medicare

67 Family Medicine doctors found. Showing 61 - 67

Ms. Manya Bernbaum, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 15 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1561    Fax: 207-626-1849

Dr. Carolyn R Pece, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Va Ctr, Augusta, ME 04330 Phone: 207-623-8411    Fax: 207-626-4787

Thomas E Liscord, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1303

Charles R Perakis, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 15 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1561    Fax: 207-626-1849

Dean Chamberlain, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1561    Fax: 207-626-1849

Shaista Khanum, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 15 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1561    Fax: 207-626-1849

Gregory Stevens, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 15 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1561    Fax: 207-626-1849

News Archive

Global leaders in medical and surgical eye care to convene in Chicago to attend AAO 2018

Thousands of eye physicians and surgeons this week will convene in Chicago to attend AAO 2018, the American Academy of Ophthalmology's 122nd annual meeting.

FDA grants orphan drug designation for Sunesis Pharmaceuticals' voreloxin

Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2 clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1, of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML.

Genetics plays a role in drug-seeking behavior

Inbred strains of rats differ in how aggressively they seek cocaine after a few weeks of use, researchers say.

AIHW report: Modifiable risk factors cause one-third of disease burden

The overall health of Australians continues to improve, however, a new report from the Australian Institute of Health and Welfare for 2018 show that further gains could be achieved by reducing leading risk factors such as tobacco use, overweight, and high blood pressure.

Read more Medical News

› Verified 9 days ago

• 1
• 2
• 3
• 4(current)